Recordati SpA (MEX:RECN) Piotroski F-Score: 5 (As of Jun. 24, 2026) — 17% Below Median


MEX:RECN Recordati SpA MEX:RECN
71 GF Score
Price MXN1,019.79
GF Value MXN1,150.22
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Recordati SpA Piotroski F-Score?

Recordati SpA MEX:RECN 71 Piotroski F-Score is 5 as of Jun. 24, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates MEX:RECN with a GF Score™ of 71/100 and a GF Value™ of MXN1,150.22 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 981 Drug Manufacturers companies, Recordati SpA ranks better than 61.26% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Recordati SpA has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Recordati SpA's Piotroski F-Score or its related term are showing as below:

MEX:RECN' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 6   Max: 9
Current: 5

During the past 13 years, the highest Piotroski F-Score of Recordati SpA was 9. The lowest was 4. And the median was 6.

Recordati SpA  (MEX:RECN) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Recordati SpA Piotroski F-Score Related Terms


Recordati SpA Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Recordati SpA's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recordati SpA Piotroski F-Score Chart

Recordati SpA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.00 4.00 5.00 8.00 4.00

Recordati SpA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 6.00 4.00 5.00

MEX:RECN vs LLY, JNJ, ABBV: Piotroski F-Score Comparison

For the Drug Manufacturers - General subindustry, Recordati SpA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA Piotroski F-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Piotroski F-Score falls into.


MEX:RECN
71GF Score
Recordati SpA MEX:RECN
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 1978.043 + 2371.935 + 2473.949 + 3190.871 = MXN10,015 Mil.
Cash Flow from Operations was 2332.106 + 3276.055 + 3638.416 + 2144.536 = MXN11,391 Mil.
Revenue was 13983.602 + 13614.346 + 13962.219 + 14872.787 = MXN56,433 Mil.
Gross Profit was 9205.025 + 9310.069 + 9965.312 + 10649.216 = MXN39,130 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(114259.423 + 112413.495 + 114085.4 + 110738.745 + 111209.454) / 5 = MXN112541.3034 Mil.
Total Assets at the begining of this year (Mar25) was MXN114,259 Mil.
Long-Term Debt & Capital Lease Obligation was MXN36,630 Mil.
Total Current Assets was MXN36,028 Mil.
Total Current Liabilities was MXN28,523 Mil.
Net Income was 2007.027 + 2470.138 + 1705.756 + 2765.528 = MXN8,948 Mil.

Revenue was 11395.282 + 12181.63 + 13069.82 + 15038.657 = MXN51,685 Mil.
Gross Profit was 7616.469 + 8416.434 + 9027.177 + 10146.648 = MXN35,207 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(77232.855 + 82839.088 + 91864.253 + 112128.433 + 114259.423) / 5 = MXN95664.8104 Mil.
Total Assets at the begining of last year (Mar24) was MXN77,233 Mil.
Long-Term Debt & Capital Lease Obligation was MXN45,327 Mil.
Total Current Assets was MXN34,633 Mil.
Total Current Liabilities was MXN21,807 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Recordati SpA's current Net Income (TTM) was 10,015. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Recordati SpA's current Cash Flow from Operations (TTM) was 11,391. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=10014.798/114259.423
=0.08764965

ROA (Last Year)=Net Income/Total Assets (Mar24)
=8948.449/77232.855
=0.11586324

Recordati SpA's return on assets of this year was 0.08764965. Recordati SpA's return on assets of last year was 0.11586324. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Recordati SpA's current Net Income (TTM) was 10,015. Recordati SpA's current Cash Flow from Operations (TTM) was 11,391. ==> 11,391 > 10,015 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=36630.376/112541.3034
=0.32548384

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=45327.033/95664.8104
=0.47381093

Recordati SpA's gearing of this year was 0.32548384. Recordati SpA's gearing of last year was 0.47381093. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=36027.583/28522.749
=1.26311749

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=34632.526/21807.247
=1.58812004

Recordati SpA's current ratio of this year was 1.26311749. Recordati SpA's current ratio of last year was 1.58812004. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Recordati SpA's number of shares in issue this year was 209.1. Recordati SpA's number of shares in issue last year was 209.099. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=39129.622/56432.954
=0.69338249

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=35206.728/51685.389
=0.68117371

Recordati SpA's gross margin of this year was 0.69338249. Recordati SpA's gross margin of last year was 0.68117371. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=56432.954/114259.423
=0.49390197

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=51685.389/77232.855
=0.66921505

Recordati SpA's asset turnover of this year was 0.49390197. Recordati SpA's asset turnover of last year was 0.66921505. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+0+0+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Recordati SpA has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Recordati SpA (MEX:RECN) has a Piotroski F-Score of 5 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Recordati SpA and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Recordati SpA's Piotroski F-Score has ranged from 4.00 to 9.00. According to the industry distribution chart, Recordati SpA ranks #380 out of 981 companies in the Drug Manufacturers industry, placing it in the top 38.7%.
Is Recordati SpA's Piotroski F-Score too high?
Recordati SpA's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. The Drug Manufacturers industry median Piotroski F-Score is 5.00. Recordati SpA's value of 5 is 0% at this industry median. Based on the distribution chart, Recordati SpA ranks #380 out of 981 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Recordati SpA has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Recordati SpA's Piotroski F-Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Recordati SpA ranks #380 out of 981 companies for Piotroski F-Score. This puts Recordati SpA in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Recordati SpA's value of 5 is 0% at this benchmark. Historically, Recordati SpA's own Piotroski F-Score has ranged from 4.00 to 9.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Recordati SpA has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Drug Manufacturers company?
The median Piotroski F-Score among Drug Manufacturers companies is 5.00, based on 981 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Recordati SpA's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Recordati SpA and its competitors. For the Drug Manufacturers industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Recordati SpA's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Recordati SpA stock overvalued right now?
Based on GuruFocus' analysis, Recordati SpA (MEX:RECN) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,150.22, compared to a current price of MXN1,019.79 — trading 11.3% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Drug Manufacturers industry median of 5.00. Recordati SpA's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Recordati SpA (MEX:RECN), the current Piotroski F-Score is 5 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Recordati SpA (MEX:RECN) Overvalued in 2026?

Based on GuruFocus' analysis, Recordati SpA stock appears to be undervalued. The current stock price of MXN1,019.79 is trading 11.3% below its estimated GF Value™ of MXN1,150.22. GuruFocus considers Recordati SpA to be Modestly Undervalued.

Key valuation signals for MEX:RECN:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: MXN1,150.22 vs. price of MXN1,019.79 (11.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs
  • Industry Position: 0% at the Drug Manufacturers median (#380 of 981)

No single metric tells the full story. See the MEX:RECN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Recordati SpA Business Description

Address Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is engaged in the development, production, and marketing of pharmaceutical products or of pharmaceutical chemicals. The Company operates in a broad and diverse context, which includes general medicine, specialist medicine, self-medication, and rare diseases. In addition, it is also active in the field of urology, with treatments for benign prostatic hyperplasia and male functional disorders, and in psychiatry. The Company's only operating segment is the Specialty & Primary Care segment. Its geographic areas are Europe, Australasia, America, and Africa.
71GF Score

Get the complete analysis for MEX:RECN

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,019.79
Price
MXN1,150.22
GF Value